• Gene Expression Regulation: DNA methylation typically suppresses gene expression. Abnormal methylation patterns can disrupt normal cellular functions and contribute to diseases such as cancer.
• Detoxification: Methylation is vital in Phase II liver detoxification, converting fat-soluble toxins into water-soluble forms for excretion. This process helps eliminate harmful substances from the body.
• Phase I: Enzymes like cytochrome P450 oxidize toxins, making them more reactive.
• Phase II: Conjugation pathways, including methylation, further process these intermediates into excretable forms.
• Methylation and Inflammation: DNA methylation regulates inflammatory gene expression. Hypomethylation of promoters like Toll-like receptor 2 (TLR2) is linked to increased pro-inflammatory responses.
• Inflammation and Detoxification: Chronic inflammation can impair detoxification pathways, leading to toxin buildup and further inflammation, creating a vicious cycle.
• Epigenetic Modifications: Inflammatory signals can induce epigenetic changes, such as DNA methylation alterations, affecting gene expression and potentially contributing to disease development.
• Autoimmune Diseases: Epigenetic changes, including DNA methylation alterations, play significant roles in autoimmune disorders like systemic lupus erythematosus.
• Cancer: Aberrant methylation patterns can lead to uncontrolled inflammation and tumor progression.
• Therapeutic Approaches: Targeting epigenetic regulators may offer new avenues for treating inflammation-related diseases.
• Gene Expression Regulation: DNA methylation typically suppresses gene expression. Abnormal methylation patterns can disrupt normal cellular functions and contribute to diseases such as cancer.
• Detoxification:
Methylation is vital in Phase II liver detoxification, converting fat-soluble toxins into water-soluble forms for excretion. This process helps eliminate harmful substances from the body.
• Phase I:
Enzymes like cytochrome P450 oxidize toxins, making them more reactive.
• Phase II:
Conjugation pathways, including methylation, further process these intermediates into excretable forms.
• Methylation and Inflammation:
DNA methylation regulates inflammatory gene expression. Hypomethylation of promoters like Toll-like receptor 2 (TLR2) is linked to increased pro-inflammatory responses.
• Inflammation and Detoxification:
Chronic inflammation can impair detoxification pathways, leading to toxin buildup and further inflammation, creating a vicious cycle.
• Epigenetic Modifications: Inflammatory signals can induce epigenetic changes, such as DNA methylation alterations, affecting gene expression and potentially contributing to disease development.
• Autoimmune Diseases: Epigenetic changes, including DNA methylation alterations, play significant roles in autoimmune disorders like systemic lupus erythematosus.
• Cancer: Aberrant methylation patterns can lead to uncontrolled inflammation and tumor progression.
• Therapeutic Approaches: Targeting epigenetic regulators may offer new avenues for treating inflammation-related diseases.